POP HEALTH FORUM: A HIMSS EVENT
Boston, MA - April 3 - 4, 2017
30 years of 3M’s clinical data, value-based care and industry-defining risk stratification. More than 53 million covered lives. Add it together for powerful, meaningful predictive analytics for population health, powered by the company you trust. 3M and Verily Life Sciences (formerly Google Life Sciences), an Alphabet company, have recently entered into a strategic agreement to develop new population health measurement technology for managing clinical and financial performance. The joint technology platform is designed to analyze quality performance data across healthcare delivery systems and patient populations, and deliver meaningful information that can be used to promote real and sustainable improvements in healthcare quality and cost.